Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

BACKGROUND: New treatments for hepatitis C (HCV) infection hold great promise for cure, but numerous challenges to diagnosing, establishing care, and receiving therapy exist. There are limited data on insurance authorization for these medications. MATERIALS AND METHODS: We performed a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Do, Albert, Mittal, Yash, Liapakis, AnnMarie, Cohen, Elizabeth, Chau, Hong, Bertuccio, Claudia, Sapir, Dana, Wright, Jessica, Eggers, Carol, Drozd, Kristine, Ciarleglio, Maria, Deng, Yanhong, Lim, Joseph K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552165/
https://www.ncbi.nlm.nih.gov/pubmed/26312999
http://dx.doi.org/10.1371/journal.pone.0135645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552165/
https://www.ncbi.nlm.nih.gov/pubmed/26312999
http://dx.doi.org/10.1371/journal.pone.0135645

Ejemplares similares